TOP STORIES

• BUSINESS MTPC Royalties Reach 19.5 Billion Yen from Out-Licensed Gilenya
  May 10, 2013

• BUSINESS Takeda Sees Sales Rise on Expanding Europe, Emerging Market Biz in FY2012, Yet Operating Profit Sags 50%
  May 10, 2013

• BUSINESS No Prospects of Reaching Agreement on Delivery Prices with Wholesalers Even after the Fiscal Year End: Pres. Tajiri of Medical System Network
  May 10, 2013

• BUSINESS Takeda to Acquire US Dengue Vaccine Developer Inviragen
  May 9, 2013

• BUSINESS IFRS Implications to Be Seen in In-Licensed Products, M&A Processing
  May 9, 2013

• ORGANIZATION Kyokai Kenpo Launches Trial Notification Service on Copayment Differences between Original, Generic Anti-Allergy Drugs
  May 8, 2013

• ACADEMIA Nat’l University Hospitals Sharing Information of Drug Purchase Prices through Central Database
  May 7, 2013

• BUSINESS Boehringer to Enter Oncology Market, Hire 100 MRs in Japan
  May 2, 2013

• BUSINESS Novartis Investigating Employee Involvement in Retracted Diovan Papers
  May 1, 2013

• REGULATORY First Committee Recommends Approval for New Gout, Hyperuricemia Treatment, Antihypertensive Tape Formulation
  May 1, 2013

• REGULATORY PMRJ Introduces “RS Expert Certification System”
  April 30, 2013

• BUSINESS Boehringer Filed NDA for Afatinib in Japan: Chairman
  April 26, 2013

• BUSINESS Edoxaban Will Be Key to Achieving Targets in Daiichi Sankyo’s New 5-Year Business Plan
  April 26, 2013

• ORGANIZATION Itsuro Yoshida of Towa Pharmaceutical Expected to Take Over as Next President of JGA
  April 25, 2013

• REGULATORY Bill to Amend PAL Will Be Submitted to Diet in May, as Instructed by PM Abe: Mr Akagawa of PFSB
  April 25, 2013

• ACADEMIA RA Treatment Guidelines to Reflect Patients’ Values and Economic Considerations as Well as Evidence
  April 24, 2013

• ACADEMIA New COPD Guidelines Recommend LAMA, LABA on Equal Footing
  April 23, 2013

• BUSINESS Pfizer-Mylan Pair’s Japan Generic Share at 2.8%, Aspire for Bigger Slice of Market
  April 22, 2013

• BUSINESS Tug-of-War over “Conflicts of Interest” (2): “Diovan Scandal” Brings Renewed Attention to COI
  April 19, 2013

• BUSINESS Novo Nordisk Ups Efforts in Basal Insulin Market, Pits Tresiba against Lantus
  April 18, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 217
• 218
• 219
• 220
• 221
• 222
• 223
• 224
• 225
• …
• Next ›
• 最終 »